| Structure |
Chemical Name |
CAS |
MF |
 |
Phthalic acid, 3,3'-azoxydi- (8CI) |
22895-28-9 |
C16H10N2O9 |
 |
Apremilast Impurity 1 |
|
|
|
|
Apremilast Impurity E |
|
|
|
|
Apixaban Impurity A |
|
|
 |
Apremilast Impurity 34 |
2469037-82-7 |
C20H20N2O7S |
 |
(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-((2-hydroxyethyl)sulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide |
|
C23H26N2O8S |
 |
1-(4-(2-methyl-6-oxopiperidin-1-yl)phenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one |
2098457-93-1 |
C21H27N3O3 |
 |
Acetamide,N-(2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)- |
6118-65-6 |
C10H8N2O3 |
 |
3-(アセチルアミノ)フタル酸 |
15371-06-9 |
C10H9NO5 |
![BenzeneMethanaMine, 4-ethoxy-3-Methoxy-a-[(Methylsulfonyl)Methyl]-](/CAS/20150408/GIF/885268-06-4.gif) |
BenzeneMethanaMine, 4-ethoxy-3-Methoxy-a-[(Methylsulfonyl)Methyl]- |
885268-06-4 |
C12H19NO4S |
 |
Apremilast Impurity 4 |
1831833-38-5 |
C12H16O4S |
 |
(S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide |
1384441-38-6 |
C21H22N2O7S |
 |
HHUBRUYPYDODRB-UHFFFAOYSA-N |
106860-70-2 |
C8H5NO5 |
![1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide](/CAS/20150408/GIF/CB32681132.gif) |
1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide |
|
C24H22ClN5O3 |
 |
APST-ZA |
635705-72-5 |
C20H22N2O6S |
|
|
Apremilast Impurity 2 |
|
|
 |
Apremilast Impurity 5 |
200710-04-9 |
C11H13NO4 |
 |
Apremilast |
1384967-20-7 |
C20H20N2O7S |
|
|
Apremilast impurity 32 |
|
|
 |
(S)-2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-5-nitroisoindoline-1,3-dione |
|
C20H20N2O8S |
 |
Apremilast impurity 18 |
1407140-51-5 |
C20H32N2O6S |
 |
1-(3,4-Dimethoxyphenyl)-2-(methylsulfonyl)ethan-1-amine |
1255909-25-1 |
C11H17NO4S |
|
|
Apremilast Impurity 30 |
|
|
 |
Apremilast Impurity 19 |
2201974-01-6 |
C22H24N2O7S |
 |
Apremilast Impurity 3 |
88687-92-7 |
C16H10N2O8 |
|
|
Apremilast impurity 15 |
|
|
 |
2-ethoxy-1-methoxy-4-(2-(methylsulfonyl)ethyl)benzene |
|
C12H18O4S |
|
|
Apixaban Impurity A25 |
|
|
|
|
NA |
|
|
 |
1,2-Benzenedicarboxylicacid,3-(hydroxyamino)-(9CI) |
202262-76-8 |
C8H7NO5 |
|
|
Apremilast Impurity F |
|
|
|
|
Apremilast Impurity C |
|
|
 |
Apremilast |
1384440-16-7 |
C19H20N2O6S |
 |
5-(1-amino-2-(methylsulfonyl)ethyl)-2-methoxyphenol |
2169153-70-0 |
C10H15NO4S |
 |
INDEX NAME NOT YET ASSIGNED |
2417213-74-0 |
C42H42N4O12S |
|
|
Apremilast Impurity 999 |
|
|
 |
5-クロロチオフェン-2-カルボン酸メチル |
35475-03-7 |
C6H5ClO2S |
|
|
Apixaban IMpurity(BMS-778960-01) |
|
|
|
|
Apremilast Impurity 20 |
|
|
 |
N-(1,3-ジヒドロ-1,3-ジオキソイソベンゾフラン-4-イル)アセトアミド |
6296-53-3 |
C10H7NO4 |
 |
3-エトキシ-4-メトキシ安息香酸 |
2651-55-0 |
C10H12O4 |
![1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid](/CAS/20130318/GIF/CB82611222.gif) |
1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid |
1696392-11-6 |
C24H21N3O4 |
|
|
AtracuriuM IMpurity I (Mixture of cis, trans(I1), cis, cis(I2), tans, trans IsoMer) |
|
|
|
|
Apixaban IMpurity(BMS-591329-01) |
|
|
|
|
ApreMilast IMpurity |
|
|
 |
Azilsartan Impurity |
1821386-21-3 |
C22H18N4O4 |
 |
1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine |
1450657-31-4 |
C12H17NO4S |
|
|
Apremilast Impurity D |
|
|
|
|
Atracurium Impurity 26 |
|
|
|
|
Apixaban Impurity BMS-A |
|
|
|
|
Apremilast Impurity 6 |
|
|
 |
Apremilast |
1384439-80-8 |
C17H16N2O6S |
|
|
Apixaban Impurity J |
|
|
 |
Benzenemethanamine, α,α'-sulfonylbis(methylene)bis[3-ethoxy-4-methoxy- |
2417213-71-7 |
C22H32N2O6S |
![(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine](/CAS/20150408/GIF/380499-06-9.gif) |
(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine |
380499-06-9 |
C20H18F7NO2 |
 |
2(1H)-Pyrimidinone,4-amino-1-b-D-arabinofuranosyl-, 3-oxide |
30902-36-4 |
C9H13N3O6 |
|
|
Aprepitant Impurity 16 |
850354-60-8 |
|
|
|
Aprepitant Impurity 35 |
|
|
 |
tert-butyl (3S,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
|
C37H43FN2O5 |
|
|
Aprepitant iMpurity 40 |
|
|
|
|
Aprepitant iMpurity43 |
|
|
 |
(3R,5R)-7-(2-(2-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
2243639-98-5 |
C33H37CaFN2O5 |
![2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1,1-Dimethylethyl Ester](/CAS/20210305/GIF/947262-20-6.gif) |
2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1,1-Dimethylethyl Ester |
947262-20-6 |
C37H41FN2O5 |
 |
アトルバスタチン環状(フルオロフェニル)ナトリウム塩不純物 |
1315629-79-8 |
C33H34FN2NaO7 |
![(2S,3R)-2-[(1S)-1-[3,5-ビス(トリフルオロメチル)フェニル]エトキシ]-3-(4-フルオロフェニル)モルホリン](/CAS/20150408/GIF/327623-37-0.gif) |
(2S,3R)-2-[(1S)-1-[3,5-ビス(トリフルオロメチル)フェニル]エトキシ]-3-(4-フルオロフェニル)モルホリン |
327623-37-0 |
C20H18F7NO2 |
![(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride](/CAS/20150408/GIF/874460-46-5.gif) |
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride |
874460-46-5 |
C20H20ClF6NO2 |
|
|
Aprepitant iMpurity B |
|
|
|
|
Aprepitant Impurity 2 |
|
|
 |
5-Methylarabinosylcytosine |
6829-31-8 |
C10H15N3O5 |
|
|
Aprepitant Impurity 24 |
|
|
 |
Aprepitant |
1242175-38-7 |
C20H18F7NO2 |
|
|
Aprepitant Impurity 32 |
|
|
 |
Aprepitant Impurity 42 |
172678-47-6 |
C20H18F7NO2 |
 |
Nsc249004 |
7428-39-9 |
C9H13N3O5 |
 |
Atorvastatin Cyclic Isopropyl Impurity |
873950-17-5 |
C33H35FN2O7 |
 |
Difluoro Atorvastatin |
693794-20-6 |
C66H66CaF4N4O10 |
 |
(3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
|
C33H35FN2O5 |
 |
(1R,2S,3S)-Aprepitant |
172822-28-5 |
C23H21F7N4O3 |
 |
2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
929540-41-0 |
C36H41CaFN2O5 |
 |
(S,E)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxyhept-2-enoic acid calcium(II) |
1659317-57-3 |
C33H35CaFN2O4 |
 |
4-(オキシラニルメトキシ)ベンゼンアセトアミド |
29122-69-8 |
C11H13NO3 |
![1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)-](/CAS/20211123/GIF/862260-38-6.gif) |
1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)- |
862260-38-6 |
C36H40FN2NaO5 |
 |
Aprepitant iMpurity |
96730-04-0 |
C13H22NO4P |
 |
Aprepitant Impurity 17 |
1333998-27-8 |
C20H19ClF7NO2 |
![2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione](/CAS/20180528/GIF/1809464-27-4.gif) |
2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione |
1809464-27-4 |
C22H17ClO3 |
|
|
Apremilast Impurity SY |
|
|
|
|
Atracurium Impurity L |
|
|
|
|
NA |
|
|
|
|
AtracuriuM IMpurity C (Mixture of DiastereoMers) |
86293-35-8 |
|
|
|
AtracuriuM IMpurity E (cis-Quaternary Acid) |
|
|
 |
Aprepitant EP Impurity B |
2206606-86-0 |
C29H25F7N4O3 |
 |
Azilsartan Impurity 16 |
1417576-00-1 |
C28H20N4O8 |
|
|
Azithromycin EP Impurity K |
|
|
|
|
Apremilast Impurity QJ |
|
|
|
|
Apremilast Impurity TTN |
|
|
 |
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10,11,13- pentahydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6- azacyclopentadecan-15-one |
117693-42-2 |
C22H43NO7 |
|
|
Atracurium Impurity 31 |
|
|
|
|
AZITHROMYCIN IMPURITY A |
|
|
|
|
Aprepitant impurity 2 |
|
|
|
|
Aprepitant impurity 4 |
|
|